Article
Profiling Studies in Ovarian Cancer: A Review
1 Aug 2007
Abstract excerpt
Ovarian cancer is a heterogeneous disease with respect to histopathology, molecular biology, and clinical outcome. In advanced stages, surgery and chemotherapy result in an approximately 25% overall 5-year survival rate, pointing to a strong need to identify subgroups of patients that may benefit from targeted innovative molecular therapy. This review summarizes: (a) microarray research identifying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
